Quantity size:
0.2ml
Concentration:
1mg/ml泛素特异性蛋白酶28抗体 Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
Deubiquitinase involved in DNA damage response checkpoint and MYC proto-oncogene stability. Involved in DNA damage induced apoptosis by specifically deubiquitinating proteins of the DNA damage pathway such as CLSPN. Also involved in G2 DNA damage checkpoint, by deubiquitinating CLSPN, and preventing its degradation by the anaphase promoting complex/cyclosome (APC/C).泛素特异性蛋白酶28抗体 In contrast, it does not deubiquitinate PLK1. Specifically deubiquitinates MYC in the nucleoplasm, leading to prevent MYC degradation by the proteasome: acts by specifically interacting with isoform 1 of FBXW7 (FBW7alpha) in the nucleoplasm and counteracting ubiquitination of MYC by the SCF(FBW7) complex. In contrast, it does not interact with isoform 4 of FBXW7 (FBW7gamma) in the nucleolus, allowing MYC degradation and explaining the selective MYC degradation in the nucleolus.
泛素特异性蛋白酶28抗体 Also known as:
Deubiquitinating enzyme 28; KIAA1515; Ubiquitin carboxyl terminal hydrolase 28; Ubiquitin carboxyl-terminal hydrolase 28; Ubiquitin specific peptidase 28; Ubiquitin specific processing protease 28; Ubiquitin specific protease 28; Ubiquitin thioesterase 28; Ubiquitin thiolesterase 28; Ubiquitin-specific-processing protease 28; UBP28_HUMAN; USP 28;泛素特异性蛋白酶28抗体 USP28; USP28 protein.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, .
●
Immunogen: KLH conjugated synthetic peptide derived from human USP28.
●
泛素特异性蛋白酶28抗体 Predicted Molecular Weight: 75, 100kDa.
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
Not yet tested in other applications.
Optimal working dilutions must be determined by the end user.
kl818Mu01血管内皮生长因子受体1(VEGFR1)多克隆抗体Polyclonal Antibody to Vascular Endothelial Growth Factor Receptor 1 (VEGFR1)
kl818Ra01血管内皮生长因子受体1(VEGFR1)多克隆抗体Polyclonal Antibody to Vascular Endothelial Growth Factor Receptor 1 (VEGFR1)
kl819Mu01再生胰岛衍生蛋白4(REG4)多克隆抗体Polyclonal Antibody to Regenerating Islet Derived Protein 4 (REG4)
kl822Hu01角蛋白17(KRT17)多克隆抗体Polyclonal Antibody to Keratin 17 (KRT17)
kl823Hu01补体成分9(C9)多克隆抗体Polyclonal Antibody to Complement Component 9 (C9)
kl823Ra01补体成分9(C9)多克隆抗体Polyclonal Antibody to Complement Component 9 (C9)
kl824Ga01核因子κB(NFκB)多克隆抗体Polyclonal Antibody to Nuclear Factor Kappa B (NFkB)
kl824Hu01核因子κB(NFκB)多克隆抗体Polyclonal Antibody to Nuclear Factor Kappa B (NFkB)
kl824Mu01核因子κB(NFκB)多克隆抗体Polyclonal Antibody to Nuclear Factor Kappa B (NFkB)
kl824Ra01核因子κB(NFκB)多克隆抗体Polyclonal Antibody to Nuclear Factor Kappa B (NFkB)
kl825Mu01核因子κB2(NFκB2)多克隆抗体Polyclonal Antibody to Nuclear Factor Kappa B2 (NFkB2)
kl826Hu01V-Rel网状内皮增生病毒癌基因同源物B(RELB)多克隆抗体Polyclonal Antibody to V-Rel Reticuloendotheliosis Viral Oncogene Homolog B (RELB)
kl827Hu01轴突生长诱向因子1(Ntn1)多克隆抗体Polyclonal Antibody to Netrin 1 (Ntn1)
kl827Mu01轴突生长诱向因子1(Ntn1)多克隆抗体Polyclonal Antibody to Netrin 1 (Ntn1)
kl827Ra01轴突生长诱向因子1(Ntn1)多克隆抗体Polyclonal Antibody to Netrin 1 (Ntn1)
kl828Hu01载脂蛋白C4(APOC4)多克隆抗体Polyclonal Antibody to Apolipoprotein C4 (APOC4)
kl828Mu01载脂蛋白C4(APOC4)多克隆抗体Polyclonal Antibody to Apolipoprotein C4 (APOC4)
kl829Hu01解整合素金属蛋白酶9(ADAM9)多克隆抗体Polyclonal Antibody to A Disintegrin And Metalloprotease 9 (ADAM9)
kl829Ra01解整合素金属蛋白酶9(ADAM9)多克隆抗体Polyclonal Antibody to A Disintegrin And Metalloprotease 9 (ADAM9)
kl830Hu01组织转谷氨酰胺酶(TGM2)多克隆抗体Polyclonal Antibody to Transglutaminase 2, Tissue (TGM2)
kl830Ra01组织转谷氨酰胺酶(TGM2)多克隆抗体Polyclonal Antibody to Transglutaminase 2, Tissue (TGM2)
kl831Hu01音猬因子(SHH)多克隆抗体Polyclonal Antibody to Hedgehog Homolog, Sonic (SHH)
更多
企业名称
上海康朗生物科技有限公司
企业信息已认证
企业类型
信用代码
310112001510759
成立日期
2015-05-29
注册资本
100
经营范围
从事生物科技技术领域内技术开发、技术咨询、技术服务、技术转让,实验分析仪器、化工产品及原料(除危险化学品、监控化学品、烟花爆竹、民用爆竹物品、易制毒化学品)、仪器仪表、环保设备、酒店用品、皮革制品、床上用品、电子产品的销售。【依法须经批准的项目,经相关部门批准后方可开展经营活动】
上海康朗生物科技有限公司
公司地址
上海市闵行区闵北路88弄1-30号第22栋BV145室
客服电话